Wednesday, September 9, 2009

Intraday action (VVUS)

AlphaNinja - US stocks up about half a percent this morning. Goldman upgraded GE shares and increased their price target, a day after JPMorgan did the same.

Among gainers is Vivus (VVUS), up 70% on positive trial data for its weight loss drug Qnexa. I am confident this drug will be more popular than Vivus' famous erectile-dysfunction pill MUSE, which has to be ingested, um, "locally."

No comments:

Post a Comment